Skip to main content
Clinical Trials/NCT02127554
NCT02127554
Completed
Not Applicable

Langzeitresultate Und Komplikationen Nach Einer Epistaxisbehandlung

University of Zurich1 site in 1 country591 target enrollmentJanuary 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Nosebleed (Epistaxis) - Posterior or Anterior
Sponsor
University of Zurich
Enrollment
591
Locations
1
Primary Endpoint
Number of patients without recurrence
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The aim of this study is to find the most agreeable and in the long term most efficient treatment for epistaxis.

Detailed Description

In the general population epistaxis occurs quite frequently. Approximately 60% of persons will be affected once in their lifetime, and 6% thereof will seek medical advice. Thereby anterior and posterior epistaxis are discerned. Anterior epistaxis is usually located at the Locus Kisselbachii, while posterior bleeds are found further back in the nose. There, most bleeds will originate from the A. sphenopalatina or the A. ethmoidalis. Different treatment modalities exist. Anterior epistaxis are usually easier to treat than posterior ones. The aim of this study is to find the most efficient treatment. This involves the assessment of long term results and potential sequelae. Existing data will be complemented with information about recurrences and complications. The question is: Which treatment method leads to the least numbers of recurrences in the long term with the fewest long term sequelae? Secondly, the most agreeable, least painful treatment method is to be identified. Therefore we will send out questionnaires to patients that were treated between March 29, 2007 and April 1st, 2008 at the Zurich University Hospital.

Registry
clinicaltrials.gov
Start Date
January 2014
End Date
December 2015
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All patients treated during the study period with known address and who did not decease in the meantime.

Exclusion Criteria

  • Insufficiently filled out questionnaires; Obvious lack of ability to remember (as tested by control questions); Known mental disability

Outcomes

Primary Outcomes

Number of patients without recurrence

Time Frame: Up to 8 years post-treatment

Secondary Outcomes

  • Discomfort caused by treatment(Up to 1 day post-treatment)

Study Sites (1)

Loading locations...

Similar Trials